Current Ratio in % of Galera Therapeutics, Inc. from Q2 2020 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Galera Therapeutics, Inc. quarterly Current Ratio history and change rate from Q2 2020 to Q3 2025.
  • Galera Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 792 %, a 37.5% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Galera Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 792 +216 +37.5% 30 Sep 2025
Q2 2025 831 +462 +125% 30 Jun 2025
Q1 2025 676 +345 +104% 31 Mar 2025
Q4 2024 685 +350 +104% 31 Dec 2024
Q3 2024 576 +262 +83.6% 30 Sep 2024
Q2 2024 368 +22.1 +6.38% 30 Jun 2024
Q1 2024 331 -60.2 -15.4% 31 Mar 2024
Q4 2023 335 -99.2 -22.8% 31 Dec 2023
Q3 2023 314 -208 -39.9% 30 Sep 2023
Q2 2023 346 -228 -39.7% 30 Jun 2023
Q1 2023 392 -218 -35.8% 31 Mar 2023
Q4 2022 435 -125 -22.3% 31 Dec 2022
Q3 2022 522 -28.7 -5.2% 30 Sep 2022
Q2 2022 574 -26.1 -4.34% 30 Jun 2022
Q1 2022 610 -40.3 -6.2% 31 Mar 2022
Q4 2021 559 -256 -31.4% 31 Dec 2021
Q3 2021 551 -429 -43.8% 30 Sep 2021
Q2 2021 601 -365 -37.8% 30 Jun 2021
Q1 2021 650 31 Mar 2021
Q4 2020 815 31 Dec 2020
Q3 2020 980 30 Sep 2020
Q2 2020 965 30 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.